Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations'), we wish to inform you that Trident Lifeline Limited has ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Trident Lifeline Limited has made an additional investment in its subsidiary, TNS Pharma Private Limited, by acquiring 10,20,000 equity shares. Despite this fresh investment, Trident Lifeline's shareholding in the subsidiary remains unchanged at 51%. This is a further capital infusion into the existing pharma subsidiary and does not alter the ownership structure.
This is a routine capital infusion into an existing subsidiary with no change in control or ownership percentage, so it is unlikely to materially impact the stock price. Shareholders should note the company's continued commitment to its pharma subsidiary.